Document:

<PAGE>

                                                                   EXHIBIT 10.44

                             Explorer Holdings, L.P.
                         4200 Texas Commerce Tower West
                                2200 Ross Avenue
                               Dallas, Texas 75201

                                January 15, 2002

Omega Healthcare Investors, Inc.
900 Victors Way, Suite 350
Ann Arbor, Michigan 48108

Ladies and Gentlemen:

         Reference is made to the Investment Agreement, dated as of October 29,
2001 (the "INVESTMENT AGREEMENT"), between Omega Healthcare Investors, Inc.
("OMEGA") and Explorer Holdings, L.P. ("EXPLORER"). We hereby agree that:

         1.       The terms and conditions of the modifications to Omega's
                  borrowing arrangements with its senior secured lenders set
                  forth in (a) Amendment No. 4 to Loan agreement dated December
                  21, 2001, by and among Omega and certain of its subsidiaries,
                  the banks executing the signature pages thereto (the "BANKS"),
                  and Fleet National Bank, as Agent for the Banks and (b)
                  Amendment No. 3 to Loan Agreement dated December 21, 2001, by
                  and among Omega and certain of its subsidiaries, the lenders
                  executing the signature pages thereto (the "LENDERS"), and The
                  Provident Bank, as Agent for the Lenders (together, the "BANK
                  Agreements") are in a form that is satisfactory to Explorer.

         2.       The effectiveness of the Bank Agreements in accordance with
                  their present terms would satisfy the condition set forth in
                  Section 5.2(c) of the Investment Agreement.

         3.       The first sentence of Section 4.5(a) of the Investment
                  Agreement is amended by deleting the language "but in no event
                  later than 90 calendar days after the date hereof" and
                  replacing it with "but in no event later than February 28,
                  2002".

<PAGE>

Omega Healthcare Investors, Inc.
January 15, 2002
Page 2

         4.       Section 7.2 of the Investment Agreement is amended and
                  restated to read as follows:

                           "7.2. TERMINATION BY PURCHASER. This Agreement may be
                  terminated by Purchaser if the Closing shall not have occurred
                  on or before February 28, 2002 (the "OUTSIDE DATE"); PROVIDED,
                  HOWEVER, that Purchaser may not terminate this Agreement
                  pursuant to this Section 7.2 if Purchaser's failure to fulfill
                  any of its obligations under this Agreement shall have been
                  the reason that the Closing shall not have occurred on or
                  before the Outside Date."

         5.       Section 8.1 of the Investment Agreement is amended by deleting
                  Omega's prior address of:

                           900 Victors Way, Suite 350
                           Ann Arbor, Michigan 48108
                           Attn: Chief Financial Officer
                           Fax No.: (734) 887-0322

                  and replacing it with Omega's current address as follows:

                           9690 Deereco Road, Suite 100
                           Timonium, Maryland 21093
                           Attn: Chief Financial Officer
                           Fax No.: (734) 887-0388

         6.       Section 4(a) of EXHIBIT A to the Investment Agreement is
                  amended by deleting "January 31, 2002" and replacing it with
                  "February 28, 2002".

         7.       Section 2.1(g) of EXHIBIT B to the Investment Agreement is
                  amended and restated to read as follows:

                                    "(g) From and after the date the
                           stockholders of the Company vote to approve the
                           amendment of the Company's Articles of Restatement
                           and bylaws to permit an increase in the size of the
                           Board to eleven (the "STOCKHOLDER APPROVAL DATE"),
                           the Company will take all actions as may be necessary
                           to appoint C. Taylor Pickett to the Board. Prior to
                           the Stockholder Approval Date, the Company covenants
                           that the total number of seats on the Board
                           (including any

<PAGE>
Omega Healthcare Investors, Inc.
January 15, 2002
Page 3

                           vacant seats) will in no event exceed nine unless
                           otherwise agreed to in writing by Stockholder or as
                           provided pursuant to the terms of the Series A, B, C
                           or D Preferred Stock in effect on the date hereof, or
                           in the case of the Series C Preferred Stock, pursuant
                           to the Amended Series C Articles Supplementary
                           contemplated by the Investment Agreement. After the
                           Stockholder Approval Date, the Company covenants that
                           the total number of seats on the Board (including any
                           vacant seats) will in no event exceed ten unless
                           otherwise agreed to in writing by Stockholder or as
                           provided pursuant to the terms of the Series A, B, C
                           or D Preferred Stock in effect on the date hereof, or
                           in the case of the Series C Preferred Stock, pursuant
                           to the Amended Series C Articles Supplementary
                           contemplated by the Investment Agreement."

         8.       Section 11(d)(x) of EXHIBIT C to the Investment Agreement is
                  amended and restated to read as follows:

                  "if to the Company, at 9690 Deereco Road, Suite 100 Timonium,
                  Maryland 21093, Attn: Chief Financial Officer; Fax No.: (734)
                  887-0388, or at such other address, notice of which is given
                  to the holders of Registrable Securities in accordance with
                  the provisions of this Section 11(d);".

         9.       The first paragraph under the heading "Subscription Period" in
                  EXHIBIT G to the Investment Agreement is amended and restated
                  to read as follows:

                  "The rights will be exercisable for a period of at least 16
                  calendar days following the Record Date (the end of such
                  period, the "EXPIRATION DATE"). The Expiration Date may be
                  extended by the Company in its sole discretion until February
                  15, 2002".

         10.      The third paragraph of the heading "Closing Condition" in
                  EXHIBIT G to the Investment Agreement is amended and restated
                  to read as follows:

                  "If the Closing Condition is not satisfied by February 28,
                  2002, the Company will terminate the rights offering."

<PAGE>

Omega Healthcare Investors, Inc.
January 15, 2002
Page 4

Except as specifically amended hereby, the terms and provisions of the
Investment Agreement are hereby ratified and confirmed in all respects and shall
remain in full force and effect as of the date it was first executed.

                           Very truly yours,

                           EXPLORER HOLDINGS, L.P.

                           By:  Explorer Holdings GenPar, LLC,
                                   its General Partner

                           By: _______________________
                               Kymberlyn J. Irvin
                               Vice President

Accepted and agreed as of
the date first written above:

OMEGA HEALTHCARE INVESTORS, INC.

By:__________________________
   C. Taylor Pickett
   Chief Executive OfficerSVB FINANCIAL SERVICES, INC.

                      2001 ADVISORY BOARD STOCK GRANT PLAN

1. PURPOSES.

               1.1. Opportunity to Receive Stock. The purpose of the Plan is to
provide a means by which the persons serving as members on the Advisory Board of
the Company or of an Affiliate of the Company may receive a grant of stock
directly from the Company. The Company, by means of the Plan, seeks to
compensate the persons now serving as Advisory Board Members of the Company
and/or of its Affiliates, to retain the services of those persons, to secure and
retain the services of new Advisory Board Members of the Company and its
Affiliates, and to provide a sense of ownership and related incentives for all
such persons to contribute their services and know-how for the success of the
Company and its Affiliates.

               1.2. Stock Grants. The Company intends that the Grants of Common
Stock issued under the Plan will provide recipient Advisory Board Members with
immediate ownership in the Company. The Company intends (but does not commit) to
register the Granted Stock under the Federal Securities Act of 1933, as amended
(the "1933 Act") and, as reasonably possible, to cover the resale of the Granted
Stock by a Grantee.

2. DEFINITIONS.

               2.1. "Advisory Board" means a board established by the Company or
an Affiliate to assist the Company or Affiliate, as the case may be, in
designing marketing strategies and in knowing about community developments.

               2.2. "Advisory Board Member" means a member of an Advisory Board.

               2.3. "Affiliate" means any corporation or other business entity
controlled by, controlling or under common control with the Company, (including
any parent or subsidiary of the Company), whether such corporations or other
business entities are now or are hereafter existing.

               2.4. "Board" means the Board of Directors of the Company.

               2.5. "Code" means the Internal Revenue Code of 1986, as amended.

               2.6. "Committee" means the Board of Directors of the Company
unless a separate Committee has been appointed by the Board in accordance with
Section 3.3 of the Plan.

               2.7. "Common Stock" means the common stock of SVB Financial
Services, Inc., a New Jersey corporation.

               2.8. "Company" means SVB Financial Services, Inc., a New Jersey
corporation.

               2.9. "Director" means a member of the Board.

<PAGE>

               2.10. "Exchange Act" means the Securities and Exchange Act of
1934, as amended.

               2.11. "Grant" means the grant of Common Stock by the Company
pursuant to the Plan.

               2.12. "Grantee" means an Advisory Board Member who has received a
Grant of Granted Stock pursuant to the Plan.

               2.13. "Grant Agreement" means a written Agreement between the
Company and a Grantee evidencing the agreements required of the Grantee with
respect to securities law compliance as a condition of the Grant. The Grant
Agreement shall be subject to the terms and conditions of the Plan.

               2.14. "Granted Stock" means with respect to a Grant, the Shares
of Common Stock covered by the Grant.

               2.15. "Plan" the SVB Financial Services, Inc. 2001 Advisory Board
Stock Grant Plan.

               2.16. "Rule 16b-3" means Rule 16b-3 of the Exchange Act or any
successor to Rule 16b-3.

               2.17. "Shares" shall mean a share of Common Stock, as adjusted in
accordance with Section 9.

3. ADMINISTRATION.

               3.1. Committee. The Plan shall be administered by the Committee.

               3.2. Powers. The Committee shall have the power, subject to, and
within the limitations of, the express provisions of the Plan to:

               (a) make Grants;

               (b) determine the Advisory Board Member to whom, and the time or
times at which, Grants shall be made and the number of shares of Granted Stock
covered by each Grant;

               (c) amend the Plan as provided in Section 10;

               (d) construe and interpret the Plan and the Grants made under it,
and to establish, amend and revoke rules and regulations for the administration
of the Plan, subject to Section 10; including correcting any defect, omission or
inconsistency in the Plan or in any Grant Agreement in any manner and to the
extent it shall deem necessary or expedient to make the Plan fully effective;

               (e) issue shares of the Company's Common Stock in connection with
a Grant;

               (f) make all other determination deemed necessary or advisable
for the administration of the Plan.

                                       2

<PAGE>

               3.3. Committee. The Board may appoint a committee composed of not
fewer than two (2) members of the Board to serve in its place with respect to
the Plan. All of the members of such Committee shall be Officers or Directors.
From time to time, the Board may increase the size of the Committee and appoint
such additional members, remove members (with or without cause) and substitute
new members of the committee, fill vacancies, (however caused) and remove
members of the committee and thereafter directly administer the Plan, all to the
extent permitted by the rules governing plans intended to qualify as a
discretionary plan under Rule 16b-3.

4. SHARES SUBJECT TO PLAN.

               4.1. Number of Shares. Subject to the provisions of Section 9
relating to adjustments upon changes in the Company Stock, up to 5,000 shares of
the Company's Common Stock are to be available under the Plan, with respect to
which Grants may be made.

               4.2. Stock Subject to Plan. The Common Stock subject to the Plan
may be either authorized but unissued shares of Common Stock or outstanding
shares of Common Stock, bought by the Company on the market or otherwise for use
under the Plan.

5. ELIGIBILITY.

               5.1. Advisory Board Members. Grants may be made under this Plan
only to Advisory Board Members.

6. GRANT AGREEMENT PROVISIONS.

               6.1. Each Grant Agreement shall be in such form and contain such
terms and conditions as the Committee shall deem appropriate. In the event that
any provision of a Grant Agreement and the Plan conflict, the provisions of the
Plan shall control.

               6.2. The provisions of each Grant Agreement shall include a
requirement that the Grantee, as an inducement and condition for the making of
the Grant, (i) provide as requested complete and accurate information concerning
the Grantee reasonably necessary for inclusion in a resale prospectus and agree
to indemnify the Company with respect to the accuracy and completeness of that
information, (ii) give written assurances satisfactory to the Company stating
that such person has no present intention of selling or otherwise distributing
the Shares of Granted Stock; and (iii) deliver such other documentation as may
be necessary to comply with Federal and state securities laws. The requirements
and any assurances given pursuant to clauses (i) and (ii) shall be inoperative
if (x) the issuance of the Shares of Granted Stock have been registered under a
then effective registration statement under the 1933 Act and all applicable
state securities laws, and such registration statement includes an effective
resale prospectus, or (y) as to any such requirement, a determination is made by
counsel for the Company that such requirement need not be met in the
circumstances under the applicable securities laws. The Company may, upon advice
of counsel to the Company, place legends on the certificates evidencing Shares
of Granted Stock issued under the Plan, as such counsel deems necessary and
appropriate in order to comply with applicable securities laws, including but
not limited to, legends restricting the transfer of the stock, and may enter
stop transfer orders against the

                                       3

<PAGE>

transfer of the Shares of Granted Stock. The Company has no obligation to
undertake registration of the Shares of Granted Stock.

7. COVENANTS OF THE COMPANY.

               7.1. Regulatory Approvals. The Company shall seek and obtain from
each regulatory commission or agency having jurisdiction over the Plan such
authority as may be required to make Grants of Granted Stock; provided, however,
that this undertaking shall not require the Company to register under the 1933
Act either the Plan or any Shares of Granted Stock. If, after reasonable
efforts, the Company is unable to obtain from such regulatory commission or
agency the authority that counsel for the Company deems necessary for the lawful
issuance of the Shares under the Plan, the Company shall, unless and until such
authority is obtained, be relieved from any liability for both failure to obtain
such authority and to issue Shares.

8. MISCELLANEOUS.

               8.1. No Right To Continue as Advisory Board Member. Nothing in
the Plan or in any instrument executed or Grant made pursuant thereto shall
confer upon any Advisory Board Member or Grantee any right to serve or to
continue to serve in the position of Advisory Board Member with the Company, or
any Affiliate or shall affect the right of the Company or any Affiliate to
terminate the service or the relationship of any Advisory Board Member or
Grantee, with or without cause.

               8.2. Date Grant Made. The date any Grant is made is the date the
Committee specifies as the date the Grant is in fact made.

               8.3. Rule 16b-3. With respect to persons subject to Section 16 of
the Exchange Act, transactions under the Plan are intended to comply with all
applicable conditions of Rule 16b-3 (to the extent such Rule applies) and, with
respect to such persons, all transactions shall be subject to such conditions
regardless of whether they are expressly set forth in the Plan or the Grant
Agreement. To the extent any provision of the Plan or action by the Committee
fails to comply, it shall not apply to such persons or their transactions and
shall be deemed null and void, to the extent permitted by law and deemed
advisable by the Committee.

8.4. Notice. Any written notice to the Company required by any of the provisions
of the Plan shall be addressed to the Secretary of the Company and shall be
               effective when it is received. Any written notice to a Grantee
required by the
Plan shall be addressed to the Grantee at the address on file for the Grantee
with the Company and shall become effective 3 days after it is mailed by
certified mail, postage prepaid to such address or at the time of delivery if
delivered sooner by messenger or overnight delivery service.

9. ADJUSTMENTS UPON CHANGES IN CAPITALIZATION OR MERGER.

               9.1. Changes in Capitalization. Subject to any required action by
the shareholders of the Company, the maximum number of Shares of Common Stock
subject to the Plan and the number of shares of Common Stock that have been
authorized for issuance under the Plan but which have not been issued as Granted
Stock shall be proportionally adjusted for any increase or decrease in the
number of issued shares of the Common Stock, resulting from a stock split, stock

                                       4

<PAGE>

dividend, combination or reclassification of shares of Common Stock effected
without consideration by the Company; provided, however that the conversion of
any convertible securities of the Company shall not be deemed to have been
effected without receipt of consideration. Such adjustment shall be made by the
Committee, whose determination in that respect shall be final, binding and
conclusive.

10. AMENDMENT OF THE PLAN.

               10.1. Amendments by the Committee. The Committee at any time,
from time to time, may amend the Plan, provided, however, that if required by
Rule 16b-3 (and it is determined that Rule 16b-3 applies to the Plan), no
amendment shall be made more than once every six months, other than to comport
with the changes in the Code, ERISA or the rules and regulations promulgated
thereunder.

               10.2. Compliance with the Code and Rule 16b-3. It is expressly
contemplated that the Committee may amend the Plan in any respect the Committee
deems necessary or advisable to bring the Plan into compliance with the Code and
Rule 16b-3, if the Committee first determines that the Code or Rule 16b-3
applies to the Plan to require such amendment.

               10.3. Shareholder Approval. Notwithstanding anything to the
contrary, the Company shall obtain shareholder approval of any Plan amendment to
the extent necessary or desirable to comply with Rule 16b-3 or with the Code (or
any successor rule or statute) or with any other applicable law, rule or
regulation, including the requirements or any exchange or quotation system on
which the Common Stock is listed or quoted. Such shareholder approval, if
required, shall be obtained in such manner and to such degree as is required by
the applicable law, rule or regulation.

               10.4. Rights and Obligations Awarded Prior to Amendments. Rights
and obligations of any Grantee under any Grant Agreement covering a Grant made
before amendment of the Plan shall not be altered or impaired by any amendment
of the Plan unless (i) the Grantee still holds the Granted Stock and (ii) the
Company requests and obtains the consent of the Grantee.

11. TERMINATION OR SUSPENSION OF THE PLAN.

               11.1. Termination Date. The Committee may suspend or terminate
the Plan at any time. Unless sooner terminated, the Plan shall terminate within
ten (10) years of the date the Plan is adopted by the Board of Directors. No
Grants may be made may be awarded under the Plan while it is suspended or after
it is terminated.

12. EFFECTIVE DATE OF PLAN.

               12.1. The Plan shall become effective as determined by the Board,
but no Grants may be made unless and until any required approval, if any, by the
shareholders of the Company of the Plan has been obtained. Continuance of the
Plan shall be subject to the approval of the Board and, if required by
applicable law, rule or regulation, including the requirements or any exchange
or quotation system on which the Common Stock is listed or quoted, the
shareholders.

                                       5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00033-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00033-of-00352.parquet"}]]